NOT FOR DISTRIBUTION
Header cover image

Thomson Medical Group

Market Cap

S$3.0b

Last Updated

2021/04/19 11:06 UTC

Data Sources

Company Financials

Executive Summary

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. More Details


Snowflake Analysis

Adequate balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Thomson Medical Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: A50 is more volatile than 75% of SG stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: A50's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of SG stocks.


Market Performance


7 Day Return

0.9%

A50

-0.7%

SG Healthcare

0.4%

SG Market


1 Year Return

90.0%

A50

42.3%

SG Healthcare

22.1%

SG Market

Return vs Industry: A50 exceeded the SG Healthcare industry which returned 42.3% over the past year.

Return vs Market: A50 exceeded the SG Market which returned 22.1% over the past year.


Shareholder returns

A50IndustryMarket
7 Day0.9%-0.7%0.4%
30 Day-4.2%-0.4%2.9%
90 Day123.5%39.7%6.5%
1 Year90.0%90.0%45.4%42.3%27.7%22.1%
3 Yearn/a-18.3%-24.6%-0.3%-12.1%
5 Yearn/a-14.2%-23.7%21.2%-0.1%

Long-Term Price Volatility Vs. Market

How volatile is Thomson Medical Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Thomson Medical Group undervalued compared to its fair value and its price relative to the market?

6.14x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: A50 (SGD0.11) is trading above our estimate of fair value (SGD0)

Significantly Below Fair Value: A50 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: A50 is unprofitable, so we can't compare its PE Ratio to the SG Healthcare industry average.

PE vs Market: A50 is unprofitable, so we can't compare its PE Ratio to the SG market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A50's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A50 is overvalued based on its PB Ratio (6.1x) compared to the SG Healthcare industry average (1.7x).


Future Growth

How is Thomson Medical Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

24.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Thomson Medical Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Thomson Medical Group performed over the past 5 years?

-95.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: A50 is currently unprofitable.

Growing Profit Margin: A50 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: A50 is unprofitable, and losses have increased over the past 5 years at a rate of 95.5% per year.

Accelerating Growth: Unable to compare A50's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A50 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-11.6%).


Return on Equity

High ROE: A50 has a negative Return on Equity (-9.14%), as it is currently unprofitable.


Financial Health

How is Thomson Medical Group's financial position?


Financial Position Analysis

Short Term Liabilities: A50's short term assets (SGD241.6M) exceed its short term liabilities (SGD73.0M).

Long Term Liabilities: A50's short term assets (SGD241.6M) do not cover its long term liabilities (SGD627.8M).


Debt to Equity History and Analysis

Debt Level: A50's debt to equity ratio (107.5%) is considered high.

Reducing Debt: A50's debt to equity ratio has reduced from 202.2% to 107.5% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable A50 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: A50 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 32.6% per year.


Dividend

What is Thomson Medical Group current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate A50's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A50's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A50's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A50's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of A50's dividend in 3 years as they are not forecast to pay a notable one for the SG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.1yrs

Average management tenure


CEO

Chiang Yin Wong (52 yo)

1.17yrs

Tenure

Dr. Chiang Yin Wong has been Executive Director and Group Chief Executive Officer of Thomson Medical Group Limited since February 1, 2020. Dr. Wong serves as an Independent Director of RHT Health Trust Man...


Leadership Team

Experienced Management: A50's management team is considered experienced (2.1 years average tenure).


Board Members

Experienced Board: A50's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: A50 insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Thomson Medical Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Thomson Medical Group Limited
  • Ticker: A50
  • Exchange: SGX
  • Founded: 1979
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: S$2.961b
  • Shares outstanding: 26.44b
  • Website: https://www.thomsonmedicalgroup.com

Number of Employees


Location

  • Thomson Medical Group Limited
  • 101 Thomson Road, No. 20-04/05
  • United Square
  • Singapore
  • 307591
  • Singapore

Listings


Biography

Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore, Malaysia, the United Kingdom, China, the Middle East, and internationally. Th...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/19 11:06
End of Day Share Price2021/04/19 00:00
Earnings2020/12/31
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.